Sandip Patel, Dan Kaufman and Patient, UC San Diego Health (IMAGE)
Caption
Sandip Patel, MD, and Dan Kaufman, MD, PhD, of UC San Diego School of Medicine enjoy a light-hearted moment before Derek Ruff receives the first treatment for cancer of a human-induced pluripotent stem cell (iPSC)-derived cell therapy called FT500.
Credit
UC San Diego Health
Usage Restrictions
Use credit as indicated
License
Licensed content